Castration Resistant Prostate Cancer Treatment Market Report

Global and China Castration Resistant Prostate Cancer Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 28, 2022
  • PAGES：135
  • REPORT CODE：GMM1416318
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Castration Resistant Prostate Cancer Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Millennium Pharmaceuticals

    • Hologic

    • Active Biotech

    • Glaxosmithkline

    • Diagnocure

    • Spectrum Pharmaceuticals

    • Bayer Healthcare Pharmaceuticals

    • Northwest Biotherapeutics

    • Abbott Laboratories

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Hormonal Therapy

    • Adding An Anti-Androgen

    • Stopping An Anti-Androgen

    • Estrogens

    • Chemotherapy

    • Radiation Therapy

    • Others

    Application:

    • Hospital

    • Ambulatory Surgical Centers

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Castration Resistant Prostate Cancer Treatment Industry Overview

      • 1.1.1 Castration Resistant Prostate Cancer Treatment Market Scope and Market Segments

      • 1.1.2 Castration Resistant Prostate Cancer Treatment Industry Characteristics

      • 1.1.3 Global and China Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Castration Resistant Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Hormonal Therapy

      • 1.2.2 Adding An Anti-Androgen

      • 1.2.3 Stopping An Anti-Androgen

      • 1.2.4 Estrogens

      • 1.2.5 Chemotherapy

      • 1.2.6 Radiation Therapy

      • 1.2.7 Others

    • 1.3 Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Ambulatory Surgical Centers

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Castration Resistant Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Castration Resistant Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Castration Resistant Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Castration Resistant Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Castration Resistant Prostate Cancer Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Castration Resistant Prostate Cancer Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Castration Resistant Prostate Cancer Treatment Industry PEST Analysis

    • 2.3 Castration Resistant Prostate Cancer Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Castration Resistant Prostate Cancer Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Castration Resistant Prostate Cancer Treatment Industry

    Chapter 3 Global and China Castration Resistant Prostate Cancer Treatment Market, by Manufacturer

    • 3.1 Global and China Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Castration Resistant Prostate Cancer Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Castration Resistant Prostate Cancer Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Castration Resistant Prostate Cancer Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Castration Resistant Prostate Cancer Treatment Market Top 3 Players

    Chapter 4 Global and China Castration Resistant Prostate Cancer Treatment Market, by Type (2017-2028)

    • 4.1 Castration Resistant Prostate Cancer Treatment Market Trend, by Type

    • 4.2 Global Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Castration Resistant Prostate Cancer Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Castration Resistant Prostate Cancer Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Castration Resistant Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Castration Resistant Prostate Cancer Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Castration Resistant Prostate Cancer Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Castration Resistant Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Castration Resistant Prostate Cancer Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Castration Resistant Prostate Cancer Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Castration Resistant Prostate Cancer Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Castration Resistant Prostate Cancer Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Castration Resistant Prostate Cancer Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Castration Resistant Prostate Cancer Treatment Market Analysis

    • 7.1 North America Castration Resistant Prostate Cancer Treatment Market, by Type

    • 7.2 North America Castration Resistant Prostate Cancer Treatment Market, by Application

    • 7.3 North America Castration Resistant Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Castration Resistant Prostate Cancer Treatment Market Analysis

    • 8.1 Europe Castration Resistant Prostate Cancer Treatment Market, by Type

    • 8.2 Europe Castration Resistant Prostate Cancer Treatment Market, by Application

    • 8.3 Europe Castration Resistant Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Castration Resistant Prostate Cancer Treatment Market Analysis

    • 9.1 APAC Castration Resistant Prostate Cancer Treatment Market, by Type

    • 9.2 APAC Castration Resistant Prostate Cancer Treatment Market, by Application

    • 9.3 APAC Castration Resistant Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Castration Resistant Prostate Cancer Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Castration Resistant Prostate Cancer Treatment Company Profiles

      • 11.1 Millennium Pharmaceuticals

        • 11.1.1 Millennium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.1.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Hologic

        • 11.2.1 Hologic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Hologic Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.2.3 Hologic Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Active Biotech

        • 11.3.1 Active Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Active Biotech Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.3.3 Active Biotech Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Glaxosmithkline

        • 11.4.1 Glaxosmithkline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.4.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Diagnocure

        • 11.5.1 Diagnocure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Diagnocure Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.5.3 Diagnocure Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Spectrum Pharmaceuticals

        • 11.6.1 Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.6.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Bayer Healthcare Pharmaceuticals

        • 11.7.1 Bayer Healthcare Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.7.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Northwest Biotherapeutics

        • 11.8.1 Northwest Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.8.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Abbott Laboratories

        • 11.9.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product Profiles, Application and Specification

        • 11.9.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Castration Resistant Prostate Cancer Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Castration Resistant Prostate Cancer Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Castration Resistant Prostate Cancer Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Hormonal Therapy (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Adding An Anti-Androgen (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Stopping An Anti-Androgen (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Estrogens (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Chemotherapy (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Radiation Therapy (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)

    • Figure North America Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Castration Resistant Prostate Cancer Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Castration Resistant Prostate Cancer Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Castration Resistant Prostate Cancer Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Castration Resistant Prostate Cancer Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Castration Resistant Prostate Cancer Treatment Market Share, by Manufacturer in 2022

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Value, by Type (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Value, by Type (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Price Trend, by Type (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Value, by Application (2017-2028)

    • Table Global Castration Resistant Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Castration Resistant Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Value, by Application (2017-2028)

    • Table China Castration Resistant Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Castration Resistant Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table North America Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Castration Resistant Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table North America Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Castration Resistant Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Castration Resistant Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Castration Resistant Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Castration Resistant Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Castration Resistant Prostate Cancer Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Castration Resistant Prostate Cancer Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Castration Resistant Prostate Cancer Treatment Sales Value and Growth Rate (2017-2028)

    • Table Millennium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Millennium Pharmaceuticals Product Profiles, Application and Specification

    • Table Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hologic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hologic Product Profiles, Application and Specification

    • Table Hologic Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Active Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Active Biotech Product Profiles, Application and Specification

    • Table Active Biotech Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Glaxosmithkline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Glaxosmithkline Product Profiles, Application and Specification

    • Table Glaxosmithkline Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Diagnocure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Diagnocure Product Profiles, Application and Specification

    • Table Diagnocure Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Spectrum Pharmaceuticals Product Profiles, Application and Specification

    • Table Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Healthcare Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Healthcare Pharmaceuticals Product Profiles, Application and Specification

    • Table Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Northwest Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Northwest Biotherapeutics Product Profiles, Application and Specification

    • Table Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Castration Resistant Prostate Cancer Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US